title: [Buspirone: a new possibility in the treatment of anxiety].
abstract: Buspiron an azaspirodecanedione, heterocyclic compound which, although structurally unrelated to the benzodiazepines, possesses comparable anxiolytic activity. Because buspirone lacks hypnotic, anticonvulsant and muscle relaxant properties, it has been termed "anxioselective". It seems unlikely to generate the problems of dependence, abuse and rebound. It does not impair psychomotor or cognitive performance and appears to have no additive effect with other CNS-active agents, particularly alcohol. Clinical trials and studies of buspiron suggest that it is an effective treatment for the relief of symptoms of anxiety, especially in patients in whom daytime alertness is particularly important.
authors.affiliation: Semmelweis Orvostudományi Egyetem, Psychiatriai és Psychotherapiás Klinika, Budapest.
authors.forename: G
authors.initials: G
authors.lastname: Faludi
mesh_terms: D001008:Anxiety Disorders / Q000188:drug therapy*; D002065:Buspirone / Q000627:therapeutic use*; D006801:Humans; D017366:Serotonin Receptor Agonists / Q000627:therapeutic use
chemical_list: D017366:Serotonin Receptor Agonists; D002065:Buspirone
vernacular_title: Buspiron: a szorongás kezelésének új lehetösége.